Search for: "Patent Docs" Results 841 - 860 of 1,613
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Aug 2007, 12:00 am
Thanks to Patent Docs for this one.What would you add? [read post]
22 May 2017, 6:39 am by Dennis Crouch
SAS Federal Circuit Decision SAS En Banc Denial SAS Petition SAS Federal Opposition SAS Reply Patent at Issue: US7110936 AIA Trial Docs: SAS IPR Petition IPR2013-00226.009 decision to institute IPR2013-00226 Final Decision IPR2013-00226 Rehearing Denial      [read post]
19 Dec 2011, 11:25 pm by Volker 'Falk' Metzler
Legal Affairs Committee MEPs backed a political deal struck last 1 December between Parliament and Council negotiators on the so-called "EU patent package" (unitary patent, language regime and unified patent court). [read post]
8 Feb 2016, 9:37 am by Dennis Crouch
§ 6(b). [6] Following professor John Duffy’s 2007 article on-point, these roles have been tightened-up. http://patentlyo.com/media/docs/2011/10/Duffy.BPAI.pdf. [read post]
28 Nov 2012, 7:06 am by Ron Coleman
Twitter: @IPWatchdog PATENT DOCS We agree with Gene Quinn over at IPWatchdog that Kevin Noonan, Donald Zuhn—both partners at Chicago’s McDonnell Boehnen Hulbert & Berghoff—and their team of contributors at Patent Docs are overdue for recognition in the IP category here. [read post]
5 Sep 2014, 7:55 am by Ron Coleman
Twitter: @IPWatchdog PATENT DOCS We agree with Gene Quinn over at IPWatchdog that Kevin Noonan, Donald Zuhn—both partners at Chicago’s McDonnell Boehnen Hulbert & Berghoff—and their team of contributors at Patent Docs are overdue for recognition in the IP category here. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Bayer AG  (FDA Law Blog) (Patent Docs) Dexilant (Dexlansoprazole) – US: Takeda files patent infringement suit against Handa following Para IV certification filing (Patent Docs) EpiPen – US: Orange Book patent delisting counterclaim raised in 505(b)(2) application patent infringement litigation; decision could provide guidance on drug delivery system patent listability: King Pharmaceuticals v Intelliject… [read post]
3 Apr 2008, 1:26 am
Lemley noted.Patent Docs has a post titled War is Peace, Freedom is Slavery, Ignorance is Strength which beginsAnd all patent rights are theft, according to The New York Times. [read post]
1 May 2009, 9:00 am
(IAM) US: Johnson & Johnson – 5 year exclusivity period would kill incentives to innovate (Patent Docs) US: CHI CEO on patent reform and follow-on biologics legislation (Patent Docs) US: BIO urges Congress on patent reform: First, do no harm (Patent Baristas) US: Pharmaceutical advertising: How to use a domain name to circumvent application of law (Domain Name / Nom De Domaine!) [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
23 Apr 2017, 3:09 pm by Lawrence B. Ebert
A comment about the CRISPR patent interference battle appeared on Patent Docs on 20 April 2017: The decisive lack of "Reasonable Expectation of Success" finding whereby inventive skill would have been required to transition the disclosed Doudna CRISPR technology platform from prokaryotes (e.g. bacteria) to eukaryotes (e.g. mammalian cells) seems doubtful when considering the course of the scientific literature that parallels the numerous patent filings. [read post]
12 Apr 2011, 10:07 pm by Marie Louise
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical… [read post]
31 Aug 2010, 10:01 pm by Kelly
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Mirapex (Pramipexole) – US: Mirapex case ends, Mylan Found to infringe Boehringer patent (Patent Docs) Moviprep (Polyethylene glycol) – US: Salix settles with Novel over Moviprep (IPBiz) Norvir (Ritonavir) – US: PUBPAT challenges eight of Abbott’s HIV/AIDS medicine patents (IP Watch) Strattera (Atomoxetine) – US: Eli Lilly granted 14-day injunction prohibiting production of… [read post]
15 Mar 2010, 3:38 am by R. David Donoghue
Senate that would require that the false patent marking plaintiff have been harmed by the alleged false marking – check out a discussion of the provision at the Patent Docs. [read post]
2 Apr 2019, 3:46 pm by Lisa Larrimore Ouellette
I noted that there were already many blogs reporting on the latest patent news (like Patently-O and Patent Docs), but that it was "much harder to find information about recent academic scholarship about patent law or broader IP theory. [read post]
19 Feb 2008, 7:10 am
At this point, of course, Doc's has only cast doubt on the validity of the '994 patent. [read post]
16 Dec 2009, 3:39 am
 (Patent Docs) (Patent Docs) US: Does the Patent Act include a written description requirement separate from the enablement requirement? [read post]
27 Oct 2010, 3:38 am by Kelly
Abbott (EPLAW) Lunesta (Eszopiclone) – US: Cobalt Pharmaceuticals and Sepracor settle Lunesta patent litigation (Patent Docs) Mirapex (Pramipexole) – US: Mylan receives approval for generic version of Mirapex tablets (SmartBrief) Oracea (Doxycyline) – US: Mylan seeks declaratory judgment of non-infringement and invalidity based on ANDA filing: Mylan v Galderma (Patent Docs) Perlane, Restylane (Hyaluronic acid) – US: Genzyme files… [read post]
27 May 2009, 5:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Pfizer acquires rights to 55 generic pills, 20 injectibles through new deals with Claris Lifesciences and Aurobindo (GenericsWeb) Sytrinol (Polymethoxylated flavones, tocotrienols) – US: District Court N D Illinois rules patent co-owned by US not immunised from infringement or validity determinations (Patent… [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat)… [read post]